BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 2581493)

  • 1. Preleukemic myelodysplastic syndromes (MDS): pathogenetical considerations based on retrospective clinicomorphological sequential studies.
    Fohlmeister I; Fischer R; Schaefer HE
    Anticancer Res; 1985; 5(2):179-88. PubMed ID: 2581493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A
    Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transformation of myelodysplastic syndromes into acute myeloid leukemias.
    Shi J; Shao ZH; Liu H; Bai J; Cao YR; He GS; Tu MF; Wang XL; Hao YS; Yang TY; Yang CL
    Chin Med J (Engl); 2004 Jul; 117(7):963-7. PubMed ID: 15265365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preleukemia].
    Janić D; Stojimirović E
    Bilt Hematol Transfuz; 1983; 11(2-3):97-103. PubMed ID: 6594995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evolution of acute leukemia in myelodysplastic syndromes: prognostic histopathological factors in a series of bone marrow biopsies].
    Navone R; Ranco V; Pich A
    Pathologica; 1991; 83(1083):55-63. PubMed ID: 1866200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro culture techniques defining biological abnormalities in the myelodysplastic syndromes and myeloproliferative disorders.
    Greenberg PL
    Clin Haematol; 1986 Nov; 15(4):973-93. PubMed ID: 3552351
    [No Abstract]   [Full Text] [Related]  

  • 8. [Study on the transformation from myelodysplastic syndromes into acute leukemias].
    Shi J; Shao Z; Liu H; Li K; Song L; Zhang Y; Zheng Y; Chen G; Chu Y; He H; Zhao M; He G; Feng B; Hao Y; Yang T; Yang C
    Zhonghua Xue Ye Xue Za Zhi; 2001 Jul; 22(7):351-4. PubMed ID: 11877096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis.
    Stifter G; Heiss S; Gastl G; Tzankov A; Stauder R
    Eur J Haematol; 2005 Dec; 75(6):485-91. PubMed ID: 16313260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Essential thrombocythemia with ringed sideroblasts: a heterogeneous spectrum of diseases, but not a distinct entity.
    Schmitt-Graeff A; Thiele J; Zuk I; Kvasnicka HM
    Haematologica; 2002 Apr; 87(4):392-9. PubMed ID: 11940483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 expression in myeloid cells of myelodysplastic syndromes. Association with evolution of overt leukemia.
    Kitagawa M; Yoshida S; Kuwata T; Tanizawa T; Kamiyama R
    Am J Pathol; 1994 Aug; 145(2):338-44. PubMed ID: 8053492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Panmyelopathy and myeloproliferative syndrome].
    Jorke D; Bach G
    Z Gesamte Inn Med; 1986 Nov; 41(21):595-8. PubMed ID: 3469815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mixed myelodysplastic and myeloproliferative syndromes].
    Neuwirtová R; Mociková K; Jelínek J; Musilová J; Havlícek F; Adamkov M; Michalová K; Cermák J; Jonásová A; Smolíková A; Straub J; Tothová E; Voglová J; Vozobulová V; Waltrová L
    Cas Lek Cesk; 1997 Dec; 136(23):724-9. PubMed ID: 9476375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of secondary hematologic disorders: preMDS-->MDS-->sAML.
    Preisler HD
    Cancer Treat Res; 2001; 108():185-230. PubMed ID: 11702600
    [No Abstract]   [Full Text] [Related]  

  • 15. [Histopathologic diagnosis of bone marrow in leukemia and related disorders].
    Kikuchi M; Ohshima K; Kobari S
    Rinsho Byori; 1991 Dec; 39(12):1245-9. PubMed ID: 1779461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preleukemic syndrome in elderly patients--report of 11 cases.
    van Dijk JM; Sonnenblick M; Kornberg A; Rosin AJ
    Isr J Med Sci; 1985 Mar; 21(3):292-5. PubMed ID: 3858273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 overexpression in myeloid leukemic disorders is associated with increased apoptosis of hematopoietic marrow cells and ineffective hematopoiesis.
    Orazi A; Kahsai M; John K; Neiman RS
    Mod Pathol; 1996 Jan; 9(1):48-52. PubMed ID: 8821956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histological and cytogenetic characterization of bone marrow in relation to prognosis and diagnosis of myelodysplastic syndromes.
    Sakuma T; Hayashi Y; Kanomata N; Murayama T; Matsui T; Kajimoto K; Hanioka K; Chihara K; Maeda S
    Pathol Int; 2006 Apr; 56(4):191-9. PubMed ID: 16634964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and cytogenetic findings of myelodysplastic syndromes showing hypocellular bone marrow or minimal dysplasia, in comparison with typical myelodysplastic syndromes.
    Toyama K; Ohyashiki K; Yoshida Y; Abe T; Asano S; Hirai H; Hirashima K; Hotta T; Kuramoto A; Kuriya S
    Int J Hematol; 1993 Aug; 58(1-2):53-61. PubMed ID: 8219112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spontaneous intramedullary apoptosis is present in disorders other than myelodysplasia.
    Irvine AE; Magill MK; Somerville LE; McMullin MF
    Exp Hematol; 1998 May; 26(5):435-9. PubMed ID: 9590661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.